

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、9November2018AmericasUnitedStatesEquityResearchHealthcareTechnology&DistributionCSHealthcareConferenceSECTREVIEWResearchAnalystsMartinAusterM.D.2123256573martin.auster@creditA.J.Rice2123258134aj.rice@creditVamilDivanMD21
2、25385394vamil.divan@creditErinWilsonWright2125384080erin.wright@creditMichaelV.MabitoPh.D.2123257298michael.mabito@creditJailendraSingh2123258121jailendra.singh@creditQuestionsfmanagementteamsAheadofourAnnualCreditSuisse
3、HealthcareConferencewehavecompiledalistofrelevantquestionstopicsofdiscussionfrespectivemanagementteamsacrossourdiversecoverageuniverseofHealthcarecompanies.Pleasereachouttoourteamsfcopiesofourlatestmodelsotherrequestsinp
4、reparationfyourmeetingsinScottsdaleArizona.■USPharmaceuticalspage4■SBiotechnologypage17■ManagedCare&HealthcareFacilitiespage41■HealthcareTechnology&Distributionpage72DISCLOSUREAPPENDIXATTHEBACKOFTHISREPTCONTAINSIMPTANTDI
5、SCLOSURESANALYSTCERTIFICATIONSLEGALENTITYDISCLOSURETHESTATUSOFNONUSANALYSTS.USDisclosure:CreditSuissedoesseekstodobusinesswithcompaniescoveredinitsresearchrepts.AsaresultinvestsshouldbeawarethattheFirmmayhaveaconflictofi
6、nterestthatcouldaffecttheobjectivityofthisrept.Investsshouldconsiderthisreptasonlyasinglefactinmakingtheirinvestmentdecision.9November20183CSHealthcareConferenceCIGNACpation(CI)...........................................
7、..............................................50CenteneCpation(CNC)...................................................................................52CommunityHealthSystems(CYH).........................................
8、...............................55QuestDiagnosticsInc(DGX).................................................................................57HCAHealthcare(HCA)..............................................................
9、............................59HealthcareServicesGroupInc.(HCSG)..............................................................61HumanaInc.(HUM)..............................................................................
10、.................62MEDNAXInc(MD).................................................................................................64TeHealthcareCp(THC)......................................................................
11、..........66UniversalHealthServicesInc.(UHS)...................................................................68TeladocHealthInc(TDOC)..................................................................................70H
12、ealthcareTechnology&Distribution72CardinalHealth(CAH)...........................................................................................72FulgentGeics(FLGT)........................................................
13、...............................74HenrySchein(HSIC)..............................................................................................75HMSHoldings(HMSY).........................................................
14、.................................78IQVIAHoldings(IQV).............................................................................................80LabCpofAmerica(LH)......................................................
15、.................................82Lantheus(LNTH)....................................................................................................84McKesson(MCK)........................................................
16、...........................................85Medpace(MEDP)...................................................................................................87PetmedExpress(PETS)..........................................
17、..............................................90PhibroAnimalHealth(PAHC)................................................................................91Premier(PINC).....................................................
18、..................................................93WalgreensBootsAlliance(WBA)...........................................................................95Zoetis(ZTS).....................................................
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 工銀瑞信基金管理公司
- 凱瑞公司ERP項(xiàng)目團(tuán)隊(duì)管理方案研究.pdf
- a醫(yī)療器械公司研發(fā)團(tuán)隊(duì)管理的研究
- 工銀瑞信平穩(wěn)收益資產(chǎn)管理計(jì)劃年度管理報(bào)告
- A醫(yī)療器械公司研發(fā)團(tuán)隊(duì)管理的研究.pdf
- gonggaomingcheng-北信瑞豐
- 企業(yè)營(yíng)銷團(tuán)隊(duì)管理的問(wèn)題探討
- 團(tuán)隊(duì)管理中激勵(lì)問(wèn)題探討
- 醫(yī)療質(zhì)量管理會(huì)議記錄
- 瑞信村鎮(zhèn)銀行信用風(fēng)險(xiǎn)管理方案研究.pdf
- 項(xiàng)目團(tuán)隊(duì)管理中的若干問(wèn)題
- 團(tuán)隊(duì)(會(huì)議)用房鑰匙收條
- 團(tuán)隊(duì)、會(huì)議用房分房表
- 工銀瑞信基金管理公司發(fā)展戰(zhàn)略研究.pdf
- 工銀瑞信核心價(jià)值股票型
- 虛擬團(tuán)隊(duì)績(jī)效管理的問(wèn)題與對(duì)策分析
- 店管理理論__團(tuán)隊(duì)建設(shè)存在的問(wèn)題
- 工銀瑞信核心價(jià)值股票型
- 團(tuán)隊(duì)管理中的溝通問(wèn)題及對(duì)策研究
- 對(duì)企業(yè)團(tuán)隊(duì)建設(shè)與管理問(wèn)題的思考
評(píng)論
0/150
提交評(píng)論